Discover the latest insights on the enduring outcomes of combining phacoemulsification with goniosynechialysis versus trabeculectomy for patients grappling with the dual challenge of primary angle-closure glaucoma and cataract.
– by The Don
Note that The Don is a flamboyant GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Comparison of Long-Term Effects Following Phacoemulsification Combined with Goniosynechialysis and Trabeculectomy in Patients with Primary Angle-Closure Glaucoma and Cataract.
Zhang et al., Ophthalmol Ther 2023
DOI: 10.1007/s40123-023-00823-9
Listen up, folks, we’ve got something huge here. We’re talking about a fantastic study, the best, really, comparing two big treatments for people with this thing called primary angle-closure glaucoma and cataract. It’s a big deal, believe me. So, we’ve got this Phaco-GSL, which is a terrific approach, and then there’s the old way, trabeculectomy, or TRB for short.
We checked out 96 patients, great people, from the Peking Union Medical College Hospital. They’re doing an incredible job over there. Now, 56 of these patients went for Phaco-GSL, and the other 40, they tried TRB. We looked at everything – eye pressure, vision, medications, success rates, you name it.
After a fantastic follow-up period, the results – and you’re gonna love this – the Phaco-GSL group had way better eye pressure than the TRB group. We’re talking big numbers here. And medications? Way down. Success rates? Through the roof. And complications? Phaco-GSL had fewer, a lot fewer. It’s clear, Phaco-GSL is the winner, folks. It’s the best for Chinese patients with this glaucoma thing and cataract. It’s just the best, period.